High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients

American Journal of Psychiatry

Volumn 152, Issue 6, 1995, Pages 876-882

  Vita, Antonio ^a   Bressi, Sergio ^b   Perani, Daniela ^b   Invernizzi, Giordano ^b   Giobbio, Gian Marco ^b   Dieci, Massimiliano ^b   Garbarini, Marco ^b   Del Sole, Angelo ^b   Fazio, Ferruccio ^b  

^a Pad Guardia II ^*  (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN PERFUSION; CEREBELLUM; CLINICAL ARTICLE; DATA ANALYSIS; DIAGNOSTIC IMAGING; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

EID: 0029045107     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.152.6.876     Document Type: Article

References (55)

1. Abou-Saleh MT (ed): Brain Imaging in Psychiatry. Br J Psychiatry 1990; 157(suppl 9)
2. Ingvar DH, Franzen G: Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974; 50:425-462
3. Ariel RN, Golden CJ, Berg RA, Quaife MA, Dirksen JW, Forsell T, Wilson J, Graber B: Regional cerebral blood flow in schizophrenics: tests using the xenon Xe 133 inhalation method. Arch Gen Psychiatry 1983; 40:258-263
4. Devous MD Sr, Raese JD, Herman JH, Stokely EM, Bonte FJ: Regional cerebral blood flow in schizophrenic patients at rest and during Wisconsin Card Sorting tasks. J Cereb Blood Flow Metab 1985; 5(Suppl):S201-S202
5. Kurachi M, Kobayashi K, Matsubara R, Hiramatsu H, Yamaguchi N, Matsuda H, Maeda T, Hisada K: Regional cerebral blood flow in schizophrenic disorders. Eur Neurol 1985; 24: 176-181
6. Chabrol H, Guell A, Bes A, Moron P: Cerebral blood flow in schizophrenic adolescents (letter). Am J Psychiatry 1986; 143: 130
7. Geraud G, Arné-Bès MC, Güell A, Bes A: Reversibility of hemodynamic hypofrontality in schizophrenia. J Cereb Blood Flow Metab 1987; 7:9-12
8. Mathew RJ, Wilson WH, Tant SR, Robinson L, Prakash R: Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. Arch Gen Psychiatry 1988; 45:542-549
9. Wilhelm KR, Schroder J, Henningsen H, Sauer H, Georgi P: Preliminary results of 99mTc-HMPAO-SPECT studies in endogenous psychoses. Nuklearmedizin 1989; 28:88-91
10. Erbas B, Hakan K, Gunaydin E, Coskun B: TC 99m-HM PAO SPECT determination of regional cerebral blood flow changes in schizophrenics. Clin Nucl Med 1990; 15:904-907
11. Paulman RG, Devous MD, Gregory RR, Herman JH, Jennings L, Bonte FJ, Nasrallah HA, Raese JD: Hypofrontality and cognitive impairment in schizophrenia: dynamic single photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry 1990; 27:377-399
12. Sagawa K, Kawakatsu S, Shibuya I, Oiji A, Morinobu S, Komatani A, Yazaki M, Totsuka S: Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients. Schizophr Res 1990; 3:241-246
13. Wood FB, Flowers DL: Hypofrontality vs hypo-Sylvian blood flow in schizophrenia. Schizophr Bull 1990; 16:413-424
14. Abdel-Dayem HM, el-Hilu S, Sehweil A, Higazi E, Jahan S, Salhat M, Almohannadi S: Cerebral perfusion changes in schizophrenic patients using Tc-99m hexamethylpropylene amineoxime (HMPAO). Clin Nucl Med 1990; 15:468-472
15. Sieg KG, Willsie DA, Preston DF, Gaffney GR: Brain imaging: evoked potential, quantitative EEG and SPECT abnormalities in schizophrenia. J Psychiatry Neurosci 1991; 16:41-44
16. Ford RA, Lewis SW, Syed GMS, Reveley A, Toone BK: Ventricular size and regional cerebral blood flow in schizophrenia: an attempted replication. Psychiatry Res: Neuroimaging 1992; 45: 209-213; correction, 1993; 50:141
17. Hawton K, Shepstone B, Soper N, Reznek L: Single-photon emission computerised tomography (SPECT) in schizophrenia. Br J Psychiatry 1990; 156:425-427
18. Mathew RJ, Meyer JS, Francis DJ, Schoolar JC, Weinman M, Mortel KF: Regional cerebral blood flow in schizophrenia: a preliminary report. Am J Psychiatry 1981; 138:112-113
19. Mathew RJ, Duncan GC, Weinman ML, Barr DL: A study of regional cerebral blood flow in schizophrenia. Arch Gen Psychiatry 1982; 39:1121-1124
20. Gur RE, Skolnick BE, Gur RC, Caroff S, Rieger W, Obrist WD, Younkin D, Reivich M: Brain function in psychiatric disorders, I: regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry 1983; 40:1250-1254
21. Dousse M, Mamo H, Ponsin JC, Dinh YT: Cerebral blood flow in schizophrenia. Exp Neurol 1988; 199:98-111
22. Bajc M, Medved V, Basic M, Topuzovic N, Babic D: Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim. Acta Psychiatr Scand 1989; 80: 427-433
23. Cohen MB, Lake RR, Graham LS, King MA, Kling AS, Fitten LJ, O'Rear J, Bronca GA, Gan M, Servrin R: Quantitative iodine-123 IMP imaging of brain perfusion in schizophrenia. J Nucl Med 1989; 30:1616-1620
24. Ebmeier KP, Blackwood HR, Murray C, Souza V, Walker M, Dougall N, Moffoot AP, O'Carroll RE, Goodwin GM: Single-photon emission computed tomography with 99mTC-exametazime in unmedicated schizophrenic patients. Biol Psychiatry 1993; 33:487-495
25. Berman KF, Zee RF, Weinberger DR: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, II: role of neuroleptic treatment, attention and mental effort. Arch Gen Psychiatry 1986; 43:126-135
26. Berman KF, Torrey EF, Daniel DG, Weinberger DR: Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992; 49:927-934
27. Weinberger DR, Berman KF, Zee RF: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry 1986; 43:114-124
28. Rubin P, Holm S, Friberg L, Videbeck P, Andersen KS, Bendsen BB, Stromso N, Larsen JK, Lassen NA, Hemmingsen R: Altered modulation of prefrontal and subcortical brain activity in newly diagnosed schizophrenia and schizophreniform disorder: a regional cerebral blood flow study. Arch Gen Psychiatry 1991; 48: 987-995
29. Rubin P, Holm S, Madsen PL, Friberg L, Videbech P, Andersen HS, Bendsen BB, Stromso N, Larsen JK, Lassen NA, Hommingsen R: Regional cerebral blood flow distribution in newly diagnosed schizophrenia and schizophreniform disorder. Psychiatry Res 1994; 53:57-75
30. Lewis SW, Ford RA, Syed GM, Reveley AM, Toone BK: A controlled study of 99mTC-HMPAO single-photon emission imaging in chronic schizophrenia. Psychol Med 1992; 22:27-35
31. Andreasen NC, Rezai K, Alliger R, Swayze VW II, Flaum M, Kirchner P, Cohen G, O'Leary DS: Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992; 49:943-958
32. O'Connell RA, Van Heertum RL, Billick SB, Holt AR, Gonzales A, Notardonato H, Luck D, King LN: Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders. J Neuropsychiatry Clin Neurosci 1989; 1:145-153
33. Kawasaki Y, Suzuki M, Maeda J, Urata K, Yamaguchi N, Matsuda H, Hisada K, Suzuki M, Takashima T: Regional cerebral blood flow in patients with schizophrenia: a preliminary report. Eur Arch Psychiatry Clin Neurosci 1992; 241:195-200
34. Matsuda H, Gyobu T, Ii M, Hisada K: Iodine-123 iodoamphetamine brain scan in a patient with auditory hallucination. J Nucl Med 1988; 29:558-560
35. Ebert D, Feistel H, Kaschka W: Left temporal hypoperfusion in catatonic syndromes: a SPECT study. Psychiatry Res: Neuroimaging 1992; 45:239-242
36. Van Heertum RL, O'Connell RA, Holt AR, Gonzales A, Notardonato H, Luck D, King LN: Evaluation of major psychoses with cerebral single photon emission computed tomography (abstract). J Nucl Med 1988; 29(Suppl):921
37. DeLisi LE, Holcomb HH, Cohen RM, Pickar D, Carpenter W, Morihisa JM, King AC, Kessler R, Buchsbaum MS: Positron emission tomography in schizophrenic patients with and without neuroleptic medication. J Cereb Blood Flow Metab 1985; 5: 201-206
38. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R: Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985; 142:564-571
39. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langstone K, Kessler R: Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry 1987; 22:479-494
40. Matsuda H, Jibiki I, Kinuya K, Kinuya S, Shuke N, Sumiya H, Tonami N, Hisada K: Tc-99m HMPAO SPECT analysis of neuroleptic effects on regional brain function. Clin Nucl Med 1991; 16:660-664
41. Berman KF, Illowsky BP, Weinberger DR: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, IV: further evidence for regional and behavioral specificity. Arch Gen Psychiatry 1988; 45:616-622
42. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
43. Andreasen NC, Flaum M, Swayze VW II, Tyrrell G, Arndt S: Positive and negative symptoms in schizophrenia: a critical reap-praisal. Arch Gen Psychiatry 1990; 47:615-621
44. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowak RS: Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992; 160:179-186
45. McGuire PK, Shah GMS, Murray RM: Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet 1993; 342:703-706
46. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1984
47. Chang LT: A method for attenuation correction in radio nuclide computed tomography. IEEE Transactions on Nuclear Science 1978;NS25:638-643
48. Damasio H, Damasio AR: Lesion Analysis in Neuropathology. New York, Oxford University Press, 1989
49. Volkow ND, Levy A, Brodie JD, Wolf AP, Cancro R, Van Gelder P, Henn F: Low cerebellar metabolism in medicated patients with chronic schizophrenia. Am J Psychiatry 1992; 149:686-688
50. Buchsbaum MS, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, Gulaserkaram B, Marshall JF, Lottemberg S, Teng CY: Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992; 49:966-974
51. Clow A, Theodorou A, Jenner P, Marsden CD: Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. Eur J Pharmacol 1980; 63: 145-157
52. Buchsbaum MS: The frontal lobes, the basal ganglia, and temporal lobes as sites of schizophrenia. Schizophr Bull 1990; 16:379-389
53. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44:660-669
54. Weinberger DR, Lipska BK: Schizophrenia and intracortical "dysconnection": new insights about psychopathology and treatment. Neuropsychopharmacology 1994; 10(suppl 3, part 1):153
55. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottemberg S, Jerabek PA, Trenary M, Tafallah R, Reynolds C, Bunney WE Jr: Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 1992; 49:935-942